| Line 20: | Line 20: | ||
==COPD== | ==COPD== | ||
===2022: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526897/ Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013–2019) of the Population Assessment of Tobacco and Health (PATH) Study]=== | |||
*E-cigarettes and all use categories involving cigarettes were associated with higher COPD prevalence compared to never use, reflecting, in part, the high burden of cigarette exposure in these groups. Cigarette—but not exclusive e-cigarette—use was also strongly associated with higher COPD incidence. Compared to cigarette use, only quitting tobacco was protective against COPD development. | |||
===2020: [https://journals.sagepub.com/doi/full/10.1177/2040622320961617 COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]=== | ===2020: [https://journals.sagepub.com/doi/full/10.1177/2040622320961617 COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]=== | ||
edits